Exclusive: CEO of Ozempic prescription startup Calibrate steps down as investors eye ‘rapid downsizing’ of consumer business
Calibrate CEO Isabelle Kenyon is stepping down as chief executive and will no longer oversee day-to-day operations.
📰 Original Source
Read full article at Fortune →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.